Skip to main content

Table 1 Baseline characteristics of patients referred for coronary artery bypass grafting

From: Perioperative outcomes of coronary artery bypass graft surgery in Johannesburg, South Africa

 

All Patients (n = 1218)

Mortality

 
  

No (n = 1081)

Yes (n = 137)

p- value

Age, years (SD)

60.1 ± 10.1

59.6 ± 10.1

63.7 ± 9.7

0.000

Male, n (%)

951 (78.1)

844 (78.1)

107 (78.1)

0.994

Ethnicity, n (%)

   

0.344

 White

634 (52.0)

569 (52.6)

65 (47.4)

 

 Indian

358 (29.4)

319 (29.5)

39 (28.5)

 

 Black

137 (11.2)

117 (10.8)

20 (14.6)

 

 Mixed ancestry

79 (6.5)

66 (6.1)

13 (9.5)

 

Medical history, n (%)

 Hypertension

908 (74.5)

813 (75.2)

95 (69.3)

0.138

 Diabetes mellitus

400 (32.8)

345 (31.9)

55 (40.1)

0.053

 Dyslipidaemia

865 (71.0)

791 (73.2)

74 (54.0)

0.000

 Stroke

32 (2.6)

27 (2.5)

5 (3.6)

0.427

 PVD

50 (4.1)

42 (3.9)

8 (5.8)

0.277

 COPD

159 (13.0)

138 (12.8)

21 (15.3)

0.402

Smoking

629 (51.6)

576 (53.3)

53 (38.7)

0.001

NYHA class, n (%)

   

0.000

 I

523 (48.1)

491 (50.7)

32 (26.9)

 

 II

396 (36.4)

344 (35.5)

52 (43.7)

 

 III

141 (13.0)

118 (12.2)

23 (19.3)

 

 IV

27 (2.5)

15 (1.5)

12 (10.1)

 

Laboratory indices

 Haemoglobin, g/dL

14.4 ± 1.7

14.5 ± 1.7

14.2 ± 1.5

0.107

 Sodium, mmol/l

140 ± 3.8

140 ± 3.7

140 ± 4.8

0.107

 eGFR, ml/min

86 (71–99)

87 (73–101)

74 (56–89)

0.000

LVEF, %

50.3 ± 12.8

51.2 ± 12.2

42.9 ± 14.8

0.000

CPB time (min)

139 (115–167)

137 (114–163)

162 (126–211)

0.000

Aortic clamp time (min)

89 (71–107)

89 (70–106)

95 (72–112)

0.107

EuroSCORE II

1.6 (0.9–3.5)

1.5 (0.9–3.1)

5.7 (2.5–10.9)

0.000

  1. Data shown as mean ± standard deviation (SD) and median and interquartile ranges for continuous variables with a normal and skewed distribution, respectively. Categorical variables are summarized as absolute numbers and percentages. COPD Chronic obstructive pulmonary disease; CPB Cardiopulmonary bypass; eGFR Estimated glomerular filtration rate; EuroSCORE European system for cardiac operative risk evaluation; LVEF Left ventricular ejection fraction; NYHA New York Heart Association; PVD Peripheral vascular disease